Chemoradiation in advanced vulval carcinoma

Vulval carcinoma is uncommon, affecting approximately 2 per 100 000 women annually. The treatment of choice is radical vulvectomy and inguinal lymph node dissection. ‘Advanced’ vulval carcinomas involve midline structures (such as clitoris, urethra or anus) and/or adjacent pelvic organs or bone, and adequate excision may require urinary diversion, colostomy or pelvic exenteration. Less morbid and less mutilating therapeutic alternatives have been investigated, particularly chemoradiation, which has shown significant success in the management of anal carcinomas. Primary chemoradiation has been used, instead of primary radical surgery, to treat advanced vulval carcinomas at Groote Schuur Hospital (GSH) since1982. Aims: 1) To assess the survival of women with advanced vulval carcinoma treated with primary chemoradiation. 2) To examine the role of surgery after treatment with primary chemoradiation.

Grantor dc:publisher.institution

Department of Obstetrics and Gynaecology

Year dc:date.issued

2008

Author dc:creator

• Rogers, Linda Joy

Advisors dc:contributor.advisor

• Denny, Lynette
• Van Wijk, A L

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/11427/3054

OAI identifier oai:identifier

oai:open.uct.ac.za:11427/3054